Nutex Health (NASDAQ:NUTX) Posts Earnings Results, Beats Estimates By $2.53 EPS

Nutex Health (NASDAQ:NUTX) released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 EPS for the quarter, topping analysts’ consensus estimates of $3.99 by $2.53, FiscalAI reports. The business had revenue of $216.49 million for the quarter, compared to analyst estimates of $227.80 million. Nutex Health had a net margin of 10.95% and a return on equity of 23.50%.

Nutex Health Stock Down 0.2%

Shares of NASDAQ:NUTX traded down $0.27 during trading on Wednesday, reaching $135.13. 6,300 shares of the stock were exchanged, compared to its average volume of 184,476. The firm has a market cap of $929.67 million, a price-to-earnings ratio of 10.44 and a beta of 0.26. The company has a debt-to-equity ratio of 0.66, a current ratio of 3.14 and a quick ratio of 3.12. Nutex Health has a 1-year low of $77.21 and a 1-year high of $193.07. The stock has a fifty day moving average of $117.26 and a two-hundred day moving average of $128.82.

Institutional Investors Weigh In On Nutex Health

Hedge funds have recently made changes to their positions in the business. BNP Paribas Financial Markets lifted its stake in Nutex Health by 966.7% in the second quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after purchasing an additional 290 shares during the last quarter. Royal Bank of Canada increased its holdings in Nutex Health by 752.4% during the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock worth $59,000 after acquiring an additional 316 shares during the period. Osaic Holdings Inc. grew its holdings in shares of Nutex Health by 280.3% during the fourth quarter. Osaic Holdings Inc. now owns 810 shares of the company’s stock worth $133,000 after purchasing an additional 597 shares in the last quarter. Vestcor Inc bought a new stake in Nutex Health during the third quarter worth about $111,000. Finally, New York State Common Retirement Fund bought a new stake in Nutex Health in the 2nd quarter worth approximately $137,000. 5.32% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

Several research firms have recently issued reports on NUTX. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. Wall Street Zen raised Nutex Health from a “hold” rating to a “buy” rating in a report on Saturday, May 9th. Finally, Lake Street Capital began coverage on Nutex Health in a research note on Tuesday, June 2nd. They issued a “buy” rating and a $235.00 price objective for the company. Two investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company’s stock. According to data from MarketBeat, Nutex Health presently has an average rating of “Moderate Buy” and a consensus target price of $220.00.

About Nutex Health

Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight?loss services and behavioral health support. By combining in?person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost?effective treatment options outside traditional hospital settings.

The company’s urgent care network operates through both standalone and retail?anchored centers, offering treatment for non?life?threatening injuries and illnesses, preventive screenings and basic primary care.